Preemptive interdural dissection in endoscopic transsphenoidal surgery for cavernous sinus medial wall resection: A technical note with step-by-step illustration
This technical note describes a step-by-step endoscopic transsphenoidal technique utilizing preemptive interdural dissection to achieve controlled resection of the cavernous sinus medial wall in functioning pituitary neuroendocrine tumors, resulting in high rates of gross total resection and biochemical remission with a favorable safety profile.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Deep within the center of the skull, nestled just behind the bridge of the nose, lies a small but vital gland called the pituitary. It acts as the body's master control center, releasing hormones that regulate growth, stress, and metabolism. Sometimes, this gland develops a tumor. While these growths are usually benign, meaning they do not spread to other parts of the body, they can be dangerous because they continue to pump out excess hormones. This hormonal overdrive can cause severe health problems, from uncontrollable growth to life-threatening metabolic shifts. To fix this, surgeons must remove the tumor. The most common way to do this is through the nose, using a narrow tunnel to reach the gland without cutting through the skull. However, a significant challenge remains: if the tumor has even the tiniest microscopic roots growing into the wall of a nearby structure called the cavernous sinus, standard removal often leaves those roots behind. These hidden remnants can cause the disease to return, leaving the patient with the same hormonal problems they started with.
A team of neurosurgeons from three hospitals in South Korea has described a refined method for tackling this specific problem. They focused on a technique to carefully remove the inner wall of the cavernous sinus, a space filled with blood vessels and nerves that sits right next to the pituitary gland. The goal was to clear away any hidden tumor tissue while keeping the surrounding critical structures safe. In a study involving ten patients with hormone-secreting tumors, the surgeons applied a new sequence of steps designed to make this delicate work safer and more precise. Their approach centers on a concept called "preemptive interdural dissection." In plain terms, this means the surgeons create a safe working space between two layers of the tough membrane covering the brain before they even touch the tumor. By doing this early, they establish a clear path that guides them later, allowing them to peel back the cavernous sinus wall with confidence rather than guessing or forcing their way through.
The procedure begins with the surgeon opening a wide path through the sphenoid sinus, the air-filled cavity behind the nose, to expose the bottom of the skull where the pituitary sits. Instead of immediately cutting into the tumor, the surgeon makes a careful incision in the outer layer of the protective membrane covering the skull base. Using a blunt instrument, they gently separate this outer layer from the inner layer, creating a small, empty space between them. This step is crucial because it happens while the tumor is still in place, keeping the area firm and the layers distinct. Once this space is established, the surgeon removes the tumor using standard techniques. After the tumor is gone, the surgeon returns to the space they created earlier. They extend this separation further, widening the corridor to reach the medial wall of the cavernous sinus. Because they have already cleared this path, they can now lift and detach the wall without having to struggle against collapsed tissue or risk tearing into the sensitive blood vessels nearby.
The results of applying this method in ten patients were encouraging. In every case, the surgeons were able to remove the entire visible tumor and the targeted section of the cavernous sinus wall. The average amount of blood lost during the surgery was 158 milliliters, a manageable amount for such a complex procedure. While three patients experienced a small leak of spinal fluid during the operation, the surgical team successfully sealed these leaks using multiple layers of repair material, and no leaks occurred after the surgery. Most importantly, the patients did not suffer from new, permanent nerve damage or injury to the major arteries in the area. At a follow-up check an average of 21 months later, nine of the ten patients had achieved complete biochemical remission, meaning their hormone levels had returned to normal and stayed that way. One patient did not reach full remission, but the overall success rate suggests the technique effectively targets the hidden disease.
The authors emphasize that this method is not a cure-all for every pituitary tumor. It is designed specifically for cases where the tumor touches the cavernous sinus wall but has not invaded it completely. If the tumor has grown deep into the sinus or wrapped around the major arteries, this approach is not suitable. The study also notes that while the technique worked well in this small group, the surgeons could not confirm with absolute certainty that every microscopic tumor cell was removed, as they did not test the removed wall tissue under a microscope for cancer cells. However, the high rate of remission and the lack of serious complications suggest that the strategy of preparing the surgical path before removing the tumor offers a practical and safer way to handle these difficult cases. By establishing a clear anatomical roadmap early in the operation, surgeons can navigate the treacherous area near the pituitary with greater control, potentially offering a better chance of a lasting cure for patients with these stubborn tumors.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.